Banu Yilmaz Ozguven

Banu Yilmaz Ozguven

Auto-generated profile, based on publicly available information

Banu Yilmaz Ozguven

Department of Pathology , Başakşehir Çam ve Sakura City Hospital , İstanbul , Türkiye

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2015 in Metabolic Syndrome and Related Disorders
Verified
Journal Article
Closed access
SBSalih Boga
Salih Boga
AKAli Riza Koksal
Ali Riza Koksal
HAHuseyin Alkim
Huseyin Alkim
MOMuveddet Banu Yilmaz Ozguven
Muveddet Banu Yilmaz Ozguven
MBMehmet Bayram
Mehmet Bayram
CACanan Alkim
Canan Alkim
Background: Nonalcoholic fatty liver disease (NAFLD) includes a variety of histopathological findings ranging from simple steatosis to nonalcoholic steatohepatitis (NASH) which can only be differentiated by liver biopsy. There is yet no unique biomarker found to discriminate NASH from simple steatosis.We aimed to investigate the relationship of plasma pentraxin 3 (PTX3) and its main stimulant tumor necrosis factor alpha (TNF-α) with the degree of liver damage in NAFLD. Methods: Plasma PTX3 and TNF-α levels were measured in 70 patients with histologically verified NAFLD (56 with NASH, 14 with non-NASH) and 12 controls. Results: PTX3 and TNF-α levels were found significantly higher in the NAFLD group than in the control group (4.1 ± 2.3 vs. 1.3 ± 0.8 ng/mL, P < 0.001, and 7.6 ± 4.1 vs. 3.3 ± 1.3 pg/mL, P < 0.001 respectively) and in biopsy proven NASH subgroup than non-NASH subgroup (4.6 ± 2.2 vs. 2.2 ± 1.7 ng/mL, P = 0.001, and 8.3 ± 4.3 vs. 4.6 ± 1.6 pg/mL, P = 0.001 respectively). To discriminate NASH from non-NASH PTX3 had 91.1% sensitivity and 71.4% specificity at the cutoff value of 2.45 ng/mL. Plasma PTX3 levels showed correlation with NAFLD activity score, fibrosis stage and steatosis grade (r = 0.659, P < 0.001; r = 0.354, P < 0.01; and r = 0.455, P < 0.001, respectively). Conclusion: This study demonstrated markedly higher PTX3 levels in NAFLD patients compared with controls, and in biopsy proven NASH patients compared with non-NASH ones. Thus, in this cohort we showed that plasma PTX3 may be a promising biomarker for the presence of NASH.

1 January 2022 in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
Verified
Journal Article
Open access
ZDZeynep Gul Demircioglu
Zeynep Gul Demircioglu
NANurcihan Aygun
Nurcihan Aygun
MDMahmut Kaan Demircioğlu
Mahmut Kaan Demircioğlu
BOBanu Yilmaz Ozguven
Banu Yilmaz Ozguven
MUMehmet Uludağ
Mehmet Uludağ
Objectives: In the present study, we investigated the effects of Vitamin D (vit D) deficiency on aggressiveness of papillary thyroid cancer (PTC). Methods: Patients with PTC confirmed with pathological examination, whom were operated by a single surgeon between 2012 and 2017, were included in the study. The data of the patients were analyzed retrospectively. Cancers other than PTC, patients with hyperthyroidism and/or using antithyroid drugs were excluded from the study. The patients were classified as four quartiles according to serum Vit D levels; category 1 (23.5 ng/mL). Results: A total of 133 patients (103 female, 30 male) with mean age of 46.4 +/- 13.6 (17-82) years were included in the study. There was no significant difference between the categories in terms of preoperative Vit D values according to the evaluated tumor aggressiveness characteristics. It was determined that the presence of tumor with a size above 1 cm and T3/4 tumor were not affected by Vit D level. There was no significant difference between Vit D categories regarding the characteristics of aggressiveness such as multicentricity, lymphovascular invasion, central, and lateral metastases. Conclusion: According to our results, serum Vit D levels are not associated with the aggressive tumor characteristics of PTC.

1 January 2019 in The Eurasian Journal of Medicine
Verified
Journal Article
Open access
EBEVREN BESLER
EVREN BESLER
BCBulent Citgez
Bulent Citgez
NANurcihan Aygun
Nurcihan Aygun
MCMustafa Fevzi Celayir
Mustafa Fevzi Celayir
MOMüyeddet Banu Yılmaz Ozguven
Müyeddet Banu Yılmaz Ozguven
MUMehmet Uludağ
Mehmet Uludağ
Objective: Thyroid-stimulating hormone/thyrotropin (TSH) is known to induce malignancies and tissue growth of the thyroid gland. While the relationship of higher levels of TSH with advanced stages of cancer had been published in previous studies, the relationship of the tumor with the clinicopathological factors had not been completely evaluated. The aim of the present study was to evaluate the relationship between highly risky clinicopathological factors with preoperative high levels of TSH. Materials and Methods: The records of 89 patients (67 females and 22 males) who underwent surgery for differentiated thyroid cancer between 2011 and 2013 were reviewed. The relationship of preoperative TSH between tumor size, multicentricity, lymphovascular invasion, extrathyroidal extension, central neck metastasis, and lateral neck metastasis was evaluated. Results: The preoperative TSH levels were high in patients with multicentricity (p=0.022), lymphovascular invasion (p=0.018), and central neck metastasis (p=0.002). The prevalence of extrathyroidal extension (p=0.41), lymphovascular invasion (p=0.020), and central metastasis (p=0.009) was significantly high in patients with a TSH level ≥2.5 mIU/L. The preoperative TSH levels were determined as an independent predictive risk factor for central neck metastases (p=0.012) and extrathyroidal extension (p=0.041) in multinomial logistical regression analysis. Conclusion: The power of radiological imaging for the identification of central neck metastases in preoperative evaluation is limited. The preoperative high level of TSH is an independent predictive factor for central metastases and extrathyroidal extension. It can help to predict tumor staging. Furthermore, related with multicentricity and lymphovascular invasion, it can affect the high risk characteristics of the tumor except the stage. The preoperative TSH level can be considered for the probability of preoperative metastases and can contribute to plan the extent of surgery. Cite this article as: Besler E, Citgez B, Aygun N, et al. The relationship of clinicopathological afactors of the tumor with preoperative TSH level in papillary thyroid cancers. Eurasian J Med 2019; 51(1): 8-11.

1 January 2024 in Revista da Associação Médica Brasileira
Verified
Journal Article
Open access
PDF file
MDMahmut Kaan Demircioğlu
Mahmut Kaan Demircioğlu
ZDZeynep Gul Demircioglu
Zeynep Gul Demircioglu
ÖÇÖzlem ÇAKIR
Özlem ÇAKIR
KYKarolin Yanar
Karolin Yanar
MOMuveddet Banu Yilmaz Ozguven
Muveddet Banu Yilmaz Ozguven
POPınar YAZICI OZKAYA
Pınar YAZICI OZKAYA
Antioxidants have been considered a rational curative strategy to prevent and cure liver diseases involving oxidative stress. An acute obstructive jaundice rat model was established to investigate the in vivo hepatoprotective efficacy of Rosa pimpinellifolia L.

1 January 2021 in SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
Verified
Journal Article
Open access
MDMahmut Kaan Demircioğlu
Mahmut Kaan Demircioğlu
ZDZeynep Gul Demircioglu
Zeynep Gul Demircioglu
NANurcihan Aygun
Nurcihan Aygun
BOBanu Yilmaz Ozguven
Banu Yilmaz Ozguven
IAIsmail Ethem Akgun
Ismail Ethem Akgun
MUMehmet Uludağ
Mehmet Uludağ
The Medical Bulletin of Sisli Etfal Hospital

1 February 2023 in Molecular Imaging and Radionuclide Therapy
Verified
Journal Article
Closed access
OEOzgul Ekmekcioglu
Ozgul Ekmekcioglu
MBMuharrem Battal
Muharrem Battal
ÖBÖzgür Bostancı
Özgür Bostancı
BÖBanu Yılmaz Özgüven
Banu Yılmaz Özgüven
18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) is a useful staging method in pancreatic cancer. The prognosis of pancreatic adenocarcinoma is affected by the tumor stage and resectable state. Maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of primary tumors are related to prognostic parameters in pancreatic cancer. This study compared 18F-FDG PET/CT findings with prognostic factors and overall survival of patients with pancreatic cancer. Patients with pancreatic adenocarcinoma, referred to our department between 2015 and 2022 for staging, were retrospectively evaluated. Head-to mid-thigh PET/CT images were obtained 1 h after 18F-FDG injection. Demographic data, survival, and clinical and pathological findings of 39 patients, who underwent surgery after PET/CT imaging, were collected. All primary tumor MTV, SUVmax, background SUVmax, and TLG data have were measured. The images of 39 patients (24 women and 15 men) with a mean age of 66.62±9.60 years were evaluated. The mean SUVmax, MTV 40%, and TLG of the primary tumors in the pancreatic tissue were 6.28±2.33, 19.33±9.77, and 66.56±45.99, respectively. The average survival after disease diagnosis was 18.97±11.47 (2-55) months. MTV and TLG were significantly higher in patients who died during our study. SUVmax has a significant effect on mortality. 18F-FDG PET/CT metabolic parameters of SUVmax, MTV, and TLG could help predicting the prognosis of pancreatic cancer preoperatively and follow-up in patients with resectable tumors. Additionally, in our study group tumor grade and perineural invasion significantly affected overall survival.